Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Gut Microbiome Testing Market

ID: MRFR/Pharma/66565-CR
130 Pages
Snehal Singh
Last Updated: April 29, 2026

Gut Microbiome Testing Market Research Report: Information by Product & Services (Instruments, Consumables and Services), By Application (16S rRNA Sequencing, Shotgun Metagenomics, Meta transcriptomics, Next Generation Sequencing, Others), By Sample Type (Stool (Fecal) Samples, Saliva Samples, Others), By Indication (Ulcerative Colitis, Irritable Bowel Syndrome (IBS), Chronic Diarrhea & Constipation, Type-2 Diabetes, Obesity, Rheumatoid Arthritis, Multiple Sclerosis, Parkinson’s Disease, Alzheimer’s Disease, Others)By End User (Hospitals, Diagnostic Laboratories, and Others), By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) -Global Forecast to 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Gut Microbiome Testing Market Infographic
Purchase Options
  1. 1 EXECUTIVE SUMMARY
  2. 2 MARKET INTRODUCTION
    1. 2.1 DEFINITION
    2. 2.2 SCOPE OF THE STUDY
    3. 2.3 RESEARCH OBJECTIVE
    4. 2.4 MARKET STRUCTURE
  3. 3 RESEARCH METHODOLOGY
    1. 3.1 OVERVIEW
    2. 3.2 DATA FLOW
      1. 3.2.1 Data Mining Process
    3. 3.3 PURCHASED DATABASE:
    4. 3.4 SECONDARY SOURCES:
      1. 3.4.1 Secondary Research data flow:
    5. 3.5 PRIMARY RESEARCH:
      1. 3.5.1 Primary Research Data Flow:
      2. 3.5.2 Primary Research: Number of Interviews conducted
      3. 3.5.3 Primary Research: Regional Coverage
    6. 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
      1. 3.6.1 Revenue Analysis Approach
    7. 3.7 DATA FORECASTING
      1. 3.7.1 Data forecasting Type
    8. 3.8 DATA MODELING
      1. 3.8.1 microeconomic factor analysis:
      2. 3.8.2 Data modeling:
    9. 3.9 TEAMS AND ANALYST CONTRIBUTION
  4. 4 MARKET DYNAMICS
    1. 4.1 INTRODUCTION
    2. 4.2 MARKET TRENDS AND GROWTH AFFECTING FACTORS
    3. 4.3 DRIVERS
      1. 4.3.1 Rising Awareness of Gut Health and Disease Linkages
      2. 4.3.2 Growth of Personalized Nutrition & Preventive Health
    4. 4.4 RESTRAINTS
      1. 4.4.1 Limited Clinical Validation & Standardization
      2. 4.4.2 Data Privacy & Integration Issues
    5. 4.5 OPPORTUNITY
      1. 4.5.1 Expansion Beyond GI Disorders
      2. 4.5.2 Partnerships & Integrated Health Solutions
  5. 5 INDUSTRY TREND ANALYSIS
    1. 5.1 REGULATORY ENVIRONMENT & COMPLIANCE
    2. 5.2 TECHNOLOGICAL TRENDS & INNOVATION
    3. 5.3 PATIENT DEMOGRAPHICS & DISEASE BURDENS
    4. 5.4 PRICING ANALYSIS & REIMBURSEMENT DYNAMICS
    5. 5.5 MARKET ENTRY & EXIT BARRIERS
    6. 5.6 PARTNERSHIPS & COLLABORATIONS
    7. 5.7 CONSUMER & HEALTHCARE PROVIDER PREFERENCES
    8. 5.8 PESTLE ANALYSIS
    9. 5.9 PORTER’S FIVE FORCES MODEL
      1. 5.9.1 Threat of New Entrants
      2. 5.9.2 Bargaining Power of Suppliers
      3. 5.9.3 Threat of Substitutes
      4. 5.9.4 Bargaining Power of Buyers
      5. 5.9.5 Intensity of Rivalry
  6. 6 GLOBAL GUT MICROBIOME TESTING MARKET, BY PRODUCT AND SERVICE
    1. 6.1 OVERVIEW
  7. 7 GLOBAL GUT MICROBIOME TESTING MARKET, BY APPLICATION
    1. 7.1 OVERVIEW
  8. 8 GLOBAL GUT MICROBIOME TESTING MARKET, BY SAMPLE TYPE
    1. 8.1 OVERVIEW
  9. 9 GLOBAL GUT MICROBIOME TESTING MARKET, BY INDICATION
    1. 9.1 OVERVIEW
  10. 10 GLOBAL GUT MICROBIOME TESTING MARKET, BY END USER
    1. 10.1 OVERVIEW
  11. 11 GLOBAL GUT MICROBIOME TESTING MARKET, BY REGION
    1. 11.1 OVERVIEW
    2. 11.2 NORTH AMERICA
      1. 11.2.1 US
      2. 11.2.2 canada
    3. 11.3 EUROPE
      1. 11.3.1 Germany
      2. 11.3.2 UK
      3. 11.3.3 FRANCE
      4. 11.3.4 Italy
      5. 11.3.5 SPAIN
      6. 11.3.6 RUSSIA
      7. 11.3.7 Rest of Europe
    4. 11.4 ASIA PACIFIC
      1. 11.4.1 CHINA
      2. 11.4.2 JAPAN
      3. 11.4.3 INDIA
      4. 11.4.4 Italy
      5. 11.4.5 INDONESIA
      6. 11.4.6 THAILAND
      7. 11.4.7 Rest of ASIA PACIFIC
    5. 11.5 SOUTH AMERICA
      1. 11.5.1 BRAZIL
      2. 11.5.2 MEXICO
      3. 11.5.3 ARGENTINA
      4. 11.5.4 REST OF SOUTH AMERICA
    6. 11.6 MIDDLE EAST & AFRICA
      1. 11.6.1 GCC COUNTRIES
      2. 11.6.2 SOUTH AFRICA
      3. 11.6.3 REST OF SOUTH AMERICA
  12. 12 COMPETITIVE LANDSCAPE
    1. 12.1 INTRODUCTION
    2. 12.2 MARKET SHARE ANALYSIS, 2024
    3. 12.3 COMPETITOR DASHBOARD
    4. 12.4 KEY DEVELOPMENTS & GROWTH STRATEGIES
      1. 12.4.1 industry key development
  13. 13 COMPANY PROFILES
    1. 13.1 VIOME, INC.
      1. 13.1.1 COMPANY OVERVIEW
      2. 13.1.2 PRODUCT OFFERed
      3. 13.1.3 SWOT ANALYSIS
      4. 13.1.4 Key Strategy
    2. 13.2 OMBRE
      1. 13.2.1 COMPANY OVERVIEW
      2. 13.2.2 PRODUCT OFFERed
      3. 13.2.3 SWOT ANALYSIS
    3. 13.3 BASECLEAR B.V.
      1. 13.3.1 COMPANY OVERVIEW
      2. 13.3.2 PRODUCT OFFERed
      3. 13.3.3 SWOT ANALYSIS
      4. 13.3.4 Key Strategy
    4. 13.4 ATLAS BIOLABS
      1. 13.4.1 COMPANY OVERVIEW
      2. 13.4.2 PRODUCT OFFERed
      3. 13.4.3 SWOT ANALYSIS
      4. 13.4.4 Key Strategy
    5. 13.5 MICROBA LIFE SCIENCES
      1. 13.5.1 COMPANY OVERVIEW
      2. 13.5.2 FINANCIAL ANALYSIS
      3. 13.5.3 PRODUCT OFFERed
      4. 13.5.4 SWOT ANALYSIS
      5. 13.5.5 Key Strategy
    6. 13.6 GENOVA DIAGNOSTICS, LTD
      1. 13.6.1 COMPANY OVERVIEW
      2. 13.6.2 PRODUCT OFFERed
      3. 13.6.3 SWOT ANALYSIS
      4. 13.6.4 Key Strategy
    7. 13.7 SUN GENOMICS, INC.
      1. 13.7.1 COMPANY OVERVIEW
      2. 13.7.2 PRODUCT OFFERed
      3. 13.7.3 SWOT ANALYSIS
      4. 13.7.4 Key Strategy
    8. 13.8 BIOHM HEALTH, INC
      1. 13.8.1 COMPANY OVERVIEW
      2. 13.8.2 PRODUCT OFFERed
      3. 13.8.3 SWOT ANALYSIS
      4. 13.8.4 Key Strategy
    9. 13.9 ZYMO RESEARCH CORPORATION
      1. 13.9.1 COMPANY OVERVIEW
      2. 13.9.2 PRODUCT OFFERed
      3. 13.9.3 SWOT ANALYSIS
      4. 13.9.4 Key Strategy
    10. 13.10 COSMOSID INC.
      1. 13.10.1 COMPANY OVERVIEW
      2. 13.10.2 PRODUCT OFFERed
      3. 13.10.3 SWOT ANALYSIS
      4. 13.10.4 Key Strategy
  14. 14 DATA CITATIONS
  15. LIST OF TABLES
  16. TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  17. TABLE 2 GLOBAL GUT MICROBIOME TESTING MARKET, BY PRODUCT AND SERVICE, 2019–2036 (USD MILLION)
  18. TABLE 3 GLOBAL GUT MICROBIOME TESTING MARKET, BY APPLICATION, 2019–2036 (USD MILLION)
  19. TABLE 4 GLOBAL GUT MICROBIOME TESTING MARKET, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  20. TABLE 5 GLOBAL GUT MICROBIOME TESTING MARKET, BY INDICATION, 2019–2036 (USD MILLION)
  21. TABLE 6 GLOBAL GUT MICROBIOME TESTING MARKET, BY END USER, 2019–2036 (USD MILLION)
  22. TABLE 7 GLOBAL GUT MICROBIOME TESTINGS MARKET, BY REGION, 2019-2035 (USD MILLION)
  23. TABLE 8 NORTH AMERICA GUT MICROBIOME TESTING MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  24. TABLE 9 NORTH AMERICA: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  25. TABLE 10 NORTH AMERICA: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  26. TABLE 11 NORTH AMERICA: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  27. TABLE 12 NORTH AMERICA: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  28. TABLE 13 NORTH AMERICA: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  29. TABLE 14 U.S.: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  30. TABLE 15 U.S.: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  31. TABLE 16 U.S.: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  32. TABLE 17 U.S.: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  33. TABLE 18 U.S.: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  34. TABLE 19 CANADA: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  35. TABLE 20 CANADA: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  36. TABLE 21 CANADA: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  37. TABLE 22 CANADA: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  38. TABLE 23 CANADA: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  39. TABLE 24 EUROPE GUT MICROBIOME TESTING MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  40. TABLE 25 EUROPE: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  41. TABLE 26 EUROPE: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  42. TABLE 27 EUROPE: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  43. TABLE 28 EUROPE: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  44. TABLE 29 EUROPE: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  45. TABLE 30 GERMANY: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  46. TABLE 31 GERMANY: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  47. TABLE 32 GERMANY: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  48. TABLE 33 GERMANY: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  49. TABLE 34 GERMANY: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  50. TABLE 35 UK: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  51. TABLE 36 UK: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  52. TABLE 37 UK: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  53. TABLE 38 UK: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  54. TABLE 39 UK: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  55. TABLE 40 FRANCE: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  56. TABLE 41 FRANCE: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  57. TABLE 42 FRANCE: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  58. TABLE 43 FRANCE: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  59. TABLE 44 FRANCE: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  60. TABLE 45 ITALY: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  61. TABLE 46 ITALY: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  62. TABLE 47 ITALY: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  63. TABLE 48 ITALY: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  64. TABLE 49 ITALY: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  65. TABLE 50 SPAIN: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  66. TABLE 51 SPAIN: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  67. TABLE 52 SPAIN: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  68. TABLE 53 SPAIN: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  69. TABLE 54 SPAIN: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  70. TABLE 55 RUSSIA: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  71. TABLE 56 RUSSIA: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  72. TABLE 57 RUSSIA: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  73. TABLE 58 RUSSIA: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  74. TABLE 59 RUSSIA: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  75. TABLE 60 REST OF EUROPE: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  76. TABLE 61 REST OF EUROPE: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  77. TABLE 62 REST OF EUROPE: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  78. TABLE 63 REST OF EUROPE: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  79. TABLE 64 REST OF EUROPE: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  80. TABLE 65 ASIA PACIFIC GUT MICROBIOME TESTING MARKET, BY COUNTRY, 2019-2036 (USD MILLION)
  81. TABLE 66 ASIA PACIFIC: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  82. TABLE 67 ASIA PACIFIC: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  83. TABLE 68 ASIA PACIFIC: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  84. TABLE 69 ASIA PACIFIC: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  85. TABLE 70 ASIA PACIFIC: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  86. TABLE 71 CHINA: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  87. TABLE 72 CHINA: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  88. TABLE 73 CHINA: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  89. TABLE 74 CHINA: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  90. TABLE 75 CHINA: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  91. TABLE 76 JAPAN: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  92. TABLE 77 JAPAN: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  93. TABLE 78 JAPAN: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  94. TABLE 79 JAPAN: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  95. TABLE 80 JAPAN: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  96. TABLE 81 INDIA: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  97. TABLE 82 INDIA: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  98. TABLE 83 INDIA: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  99. TABLE 84 INDIA: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  100. TABLE 85 INDIA: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  101. TABLE 86 SOUTH KOREA: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  102. TABLE 87 SOUTH KOREA: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  103. TABLE 88 SOUTH KOREA: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  104. TABLE 89 SOUTH KOREA: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  105. TABLE 90 SOUTH KOREA: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  106. TABLE 91 INDONESIA: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  107. TABLE 92 INDONESIA: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  108. TABLE 93 INDONESIA: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  109. TABLE 94 INDONESIA: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  110. TABLE 95 INDONESIA: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  111. TABLE 96 THAILAND: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  112. TABLE 97 THAILAND: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  113. TABLE 98 THAILAND: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  114. TABLE 99 THAILAND: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  115. TABLE 100 THAILAND: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  116. TABLE 101 REST OF ASIA PACIFIC: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  117. TABLE 102 REST OF ASIA PACIFIC: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  118. TABLE 103 REST OF ASIA PACIFIC: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  119. TABLE 104 REST OF ASIA PACIFIC: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  120. TABLE 105 REST OF ASIA PACIFIC: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  121. TABLE 106 SOUTH AMERICA GUT MICROBIOME TESTING MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  122. TABLE 107 SOUTH AMERICA: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  123. TABLE 108 SOUTH AMERICA: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  124. TABLE 109 SOUTH AMERICA: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  125. TABLE 110 SOUTH AMERICA: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  126. TABLE 111 SOUTH AMERICA: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  127. TABLE 112 BRAZIL: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  128. TABLE 113 BRAZIL: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  129. TABLE 114 BRAZIL: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  130. TABLE 115 BRAZIL: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  131. TABLE 116 BRAZIL: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  132. TABLE 117 MEXICO: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  133. TABLE 118 MEXICO: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  134. TABLE 119 MEXICO: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  135. TABLE 120 MEXICO: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  136. TABLE 121 MEXICO: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  137. TABLE 122 ARGENTINA: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  138. TABLE 123 ARGENTINA: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  139. TABLE 124 ARGENTINA: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  140. TABLE 125 ARGENTINA: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  141. TABLE 126 ARGENTINA: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  142. TABLE 127 REST OF SOUTH AMERICA: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  143. TABLE 128 REST OF SOUTH AMERICA: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  144. TABLE 129 REST OF SOUTH AMERICA: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  145. TABLE 130 REST OF SOUTH AMERICA: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  146. TABLE 131 REST OF SOUTH AMERICA: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  147. TABLE 132 MIDDLE EAST & AFRICA: GUT MICROBIOME TESTING, BY COUNTRY, 2019-2035 (USD MILLION)
  148. TABLE 133 MIDDLE EAST & AFRICA: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  149. TABLE 134 MIDDLE EAST & AFRICA: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  150. TABLE 135 MIDDLE EAST & AFRICA: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  151. TABLE 136 MIDDLE EAST & AFRICA: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  152. TABLE 137 MIDDLE EAST & AFRICA: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  153. TABLE 138 GCC COUNTRIES: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  154. TABLE 139 GCC COUNTRIES: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  155. TABLE 140 GCC COUNTRIES: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  156. TABLE 141 GCC COUNTRIES: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  157. TABLE 142 GCC COUNTRIES: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  158. TABLE 143 SOUTH AFRICA: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  159. TABLE 144 SOUTH AFRICA: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  160. TABLE 145 SOUTH AFRICA: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  161. TABLE 146 SOUTH AFRICA: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  162. TABLE 147 SOUTH AFRICA: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  163. TABLE 148 REST OF MIDDLE EAST & AFRICA: GUT MICROBIOME TESTING, BY PRODUCT & SERVICE, 2019–2036 (USD MILLION)
  164. TABLE 149 REST OF MIDDLE EAST & AFRICA: GUT MICROBIOME TESTING, BY APPLICATION, 2019–2036 (USD MILLION)
  165. TABLE 150 REST OF MIDDLE EAST & AFRICA: GUT MICROBIOME TESTING, BY SAMPLE TYPE, 2019–2036 (USD MILLION)
  166. TABLE 151 REST OF MIDDLE EAST & AFRICA: GUT MICROBIOME TESTING, BY INDICATION, 2019–2036 (USD MILLION)
  167. TABLE 152 REST OF MIDDLE EAST & AFRICA: GUT MICROBIOME TESTING, BY END USER, 2019–2036 (USD MILLION)
  168. TABLE 153 INDUSTRY KEY DEVELOPMENT
  169. TABLE 154 VIOME, INC.: PRODUCTS OFFERED
  170. TABLE 155 OMBRE: PRODUCTS OFFERED
  171. TABLE 156 BASECLEAR B.V: PRODUCTS OFFERED
  172. TABLE 157 ATLAS BIOLABS: PRODUCTS OFFERED
  173. TABLE 158 MICROBA LIFE SCIENCES.: PRODUCTS OFFERED
  174. TABLE 159 GENOVA DIAGNOSTICS, INC.: PRODUCTS OFFERED
  175. TABLE 160 SUN GENOMICS INC.: PRODUCTS OFFERED
  176. TABLE 161 BIOHM HEALTH INC.: PRODUCTS OFFERED
  177. TABLE 162 ZYMO RESEARCH CORPORATION: PRODUCTS OFFERED
  178. TABLE 163 COSMOSID INC.: PRODUCTS OFFERED
  179. LIST OF FIGURES
  180. FIGURE 1 GLOBAL GUT MICROBES TESTING MARKET: STRUCTURE
  181. FIGURE 2 GUT MICROBIOME TESTING MARKET: MARKET TRENDS AND GROWTH AFFECTING FACTORS (2025-2035)
  182. FIGURE 3 PORTER’S FIVE FORCES MODEL: GLOBAL GUT MICROBIOME TESTING MARKET
  183. FIGURE 4 GLOBAL GUT MICROBIOME TESTING MARKET, PRODUCT AND SERVICE SEGMENT ATTRACTIVENESS, 2024 & 2036 (USD MILLION)
  184. FIGURE 5 GLOBAL GUT MICROBIOME TESTING MARKET SHARE (%), BY PRODUCT AND SERVICE, 2024
  185. FIGURE 6 GLOBAL GUT MICROBIOME TESTING MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2024 & 2036 (USD MILLION)
  186. FIGURE 7 GLOBAL GUT MICROBIOME TESTING MARKET SHARE (%), BY APPLICATION, 2024
  187. FIGURE 8 GLOBAL GUT MICROBIOME TESTING MARKET, SAMPLE TYPE SEGMENT ATTRACTIVENESS, 2024 & 2036 (USD MILLION)
  188. FIGURE 9 GLOBAL GUT MICROBIOME TESTING MARKET SHARE (%), BY SAMPLE TYPE, 2024
  189. FIGURE 10 GLOBAL GUT MICROBIOME TESTING MARKET, INDICATION SEGMENT ATTRACTIVENESS, 2024 & 2036 (USD MILLION)
  190. FIGURE 11 GLOBAL GUT MICROBIOME TESTING MARKET SHARE (%), BY INDICATION, 2024
  191. FIGURE 12 GLOBAL GUT MICROBIOME TESTING MARKET, END USER SEGMENT ATTRACTIVENESS, 2024 & 2036 (USD MILLION)
  192. FIGURE 13 GLOBAL GUT MICROBIOME TESTING MARKET SHARE (%), BY END USER, 2024
  193. FIGURE 14 GLOBAL GUT MICROBIOME TESTING MARKET, BY REGION, 2024 (% SHARE)
  194. FIGURE 15 NORTH AMERICA MARKET SWOT ANALYSIS: GUT MICROBIOME TESTING
  195. FIGURE 16 NORTH AMERICA GUT MICROBIOME TESTING MARKET SHARE (%), BY COUNTRY, 2024
  196. FIGURE 17 EUROPE MARKET SWOT ANALYSIS: GUT MICROBIOME TESTING
  197. FIGURE 18 EUROPE GUT MICROBIOME TESTING MARKET SHARE (%), BY COUNTRY, 2024
  198. FIGURE 19 ASIA PACIFIC MARKET: SWOT ANALYSIS
  199. FIGURE 20 ASIA PACIFIC GUT MICROBIOME TESTING MARKET SHARE (%), BY COUNTRY, 2024
  200. FIGURE 21 SOUTH AMERICA MARKET: SWOT ANALYSIS
  201. FIGURE 22 SOUTH AMERICA GUT MICROBIOME TESTING MARKET SHARE (%), BY COUNTRY, 2024
  202. FIGURE 23 MIDDLE EAST AND AFRICA MARKET SWOT ANALYSIS: GUT MICROBIOME TESTING
  203. FIGURE 24 MIDDLE EAST & AFRICA: GUT MICROBIOME TESTING SHARE (%), BY COUNTRY, 2024
  204. FIGURE 25 GUT MICROBIOME TESTING MARKET: COMPETITIVE ANALSIS, 2024
  205. FIGURE 26 COMPETITOR DASHBOARD: GUT MICROBIOME TESTING MARKET
  206. FIGURE 27 VIOME, INC.: SWOT ANALYSIS
  207. FIGURE 28 OMBRE: SWOT ANALYSIS
  208. FIGURE 29 BASECLEAR B.V: SWOT ANALYSIS
  209. FIGURE 30 ATLAS BIOLABS: SWOT ANALYSIS
  210. FIGURE 31 MICROBA LIFE SCIENCES.: SWOT ANALYSIS
  211. FIGURE 32 GENOVA DIAGNOSTICS, INC.: SWOT ANALYSIS
  212. FIGURE 33 SUN GENOMICS INC.: SWOT ANALYSIS
  213. FIGURE 34 BIOHM HEALTH INC.: SWOT ANALYSIS
  214. FIGURE 35 ZYMO RESEARCH CORPORATION: SWOT ANALYSIS
  215. FIGURE 36 COSMOSID INC.: SWOT ANALYSIS

Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)

  • Instruments
  • Consumables
  • Services

Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)

  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others

Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)

  • Stool (Fecal) Samples
  • Saliva Samples
  • Others

Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)

  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others

Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)

  • Hospitals
  • Diagnostic Laboratories

Gut Microbiome Testing Market Regional Outlook (USD Million, 2019-2035)

  • North America Outlook (USD Million, 2019-2035)
  • North America Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • North America Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • North America Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • North America Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • North America Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • US Outlook (USD Million, 2019-2035)
  • US Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • US Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • US Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • US Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • US Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • Canada Outlook (USD Million, 2019-2035)
  • Canada Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Canada Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Canada Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Canada Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Canada Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
  • Europe Outlook (USD Million, 2019-2035)
  • Europe Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Europe Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Europe Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Europe Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • GermanyOutlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • UK Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories

 

  • France Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • Russia Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • Italy Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • Spain Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • Rest Of Europe Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
  • Asia-Pacific Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • China Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • India Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • Japan Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • South Korea Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • Rest of Asia-Pacific Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
  • South America Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • Brazil Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • Mexico Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • Argentina Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • Rest of South America Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
  • Middle East & Africa Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • GCC Countries Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • South Africa Outlook (USD Million, 2019-2035)
  • Global Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Global Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Global Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Global Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Global Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories
    • Rest of Middle East & Africa Outlook (USD Million, 2019-2035)
  • Rest of Middle East & Africa Gut Microbiome Testing Market by Product & Services Outlook (USD Million, 2019-2035)
  • Instruments
  • Consumables
  • Services
  • Rest of Middle East & Africa Gut Microbiome Testing Market by Application Outlook (USD Million, 2019-2035)
  • 16S rRNA Sequencing
  • Shotgun Metagenomics
  • Metatranscriptomics
  • Next Generation Sequencing
  • Others
  • Rest of Middle East & Africa Gut Microbiome Testing Market by Sample Type Outlook (USD Million, 2019-2035)
  • Stool (Fecal) Samples
  • Saliva Samples
  • Others
  • Rest of Middle East & Africa Gut Microbiome Testing Market by Indication Outlook (USD Million, 2019-2035)
  • Ulcerative Colitis
  • Irritable Bowel Syndrome (IBS)
  • Chronic Diarrhea & Constipation
  • Type-2 Diabetes
  • Obesity
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Parkinson’s disease
  • Alzheimer’s disease
  • Others
  • Rest of Middle East & Africa Gut Microbiome Testing Market by End User Outlook (USD Million, 2019-2035)
  • Hospitals
  • Diagnostic Laboratories

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions